ロード中...
Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium
For decades, there has been a distinct disconnect translating a compound’s effects from basic neuroscience into clinical efficacy. This disconnect has not only been in terms of generating approved compounds, but also in rejecting targets. During the drug discovery process there are key points to be...
保存先:
| 出版年: | Innov Clin Neurosci |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Matrix Medical Communications
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4571292/ https://ncbi.nlm.nih.gov/pubmed/25977839 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|